Key Dates

Related Announcements

RFA-RM-21-022 - Transformative Research to Address Health Disparities and Advance Health Equity at Minority Serving Institutions (U01 Clinical Trial Allowed)

Issued by

Office of Strategic Coordination (Common Fund)

Purpose

This Notice informs applicants of the addition of requested Institutional Information for applications submitted in response to RFA-RM-21-022.

Language added:

Part 2 Section IV. Application and Submission Information

2. Content and Form of Application Submission

SF424(R&R) Other Project Information

NIH requests that applications include the following information in an attachment titled "Institutional Information":

1) Description and evidence of the institution's explicit historical mission to educate students from backgrounds nationally underrepresented in biomedical research, or efforts to provide services to the underserved community.

• For institutions whose historical mission explicitly states that it was founded to educate students from nationally underrepresented backgrounds in biomedical research (i.e., underrepresented racial and ethnic groups [African Americans, Hispanic Americans, American Indians or Alaska Natives, Native Hawaiians, U.S. Pacific Islanders, and individuals with disabilities] and/or students from financially disadvantaged backgrounds, as defined in NOT-OD-18-210) provide the institution's original mission statement and any other information that justified the institution's creation and describes its main functions and services provided.

• For institutions whose mission statements do not explicitly state that they were founded to educate underrepresented groups mentioned above but enroll at least 25% of undergraduate students supported by Pell grants, provide the most recent two years of Pell grant support data available from the Integrated Postsecondary Education Data System (IPEDS) database maintained by the National Center for Education Statistics.

2) NIH Research Project Grants (RPGs) support (total costs) in each of the preceding two fiscal years, calculated using NIH RePORTER.

All other aspects of this Funding Opportunity remain unchanged.

Inquiries

Please direct all inquiries to:

Stephanie Courchesne-Schlink
Office of the Director
Email: [email protected]